Friday, July 24, 2026

VIDEO: Is Oklahoma Set to Execute an Innocent Man? Inside the Case of Richard...

Oklahoma is scheduled to execute Richard Glossip on Wednesday night. But as time is running out, is the state about to kill an innocent man? Democracy Now discusses the case.

Three insidious ways ‘overtaxed’ corporations are cheating America

The tax money withheld by the big corporations is desperately needed to restore living-wage opportunities to millions of workers.

New York bans native wildlife killing competitions

The statewide law, signed by New York Governor Kathy Hochul, "prohibits events during which contestants compete to kill the most, the heaviest, and the smallest animals for cash and prizes."

3 reasons Trump’s EPA pick can’t be trusted with climate science

This is why the man chosen to lead this agency needs to manage science responsibly so it can do its job.

We’re entering a new phase of the resistance

We must stay ready and not assume that because Democrats won the elections this time, we’re safe.

Oxfam reveals how rich nations are helping for-profit health industry exploit poor patients

Development finance institutions run by wealthy countries have fueled "a free-for-all of private greed over public good," the humanitarian group shows in a new report.
video

Psychologist: Separating children at the border creates trauma passed down through generations

"We speak with Dr. Dana Sinopoli, a psychologist who penned an open letter condemning the Trump administration’s practice of separating children from their parents at the border."

Inside the chaotic charter schools run by a for-profit company

Former teachers and board members say charters run by Accel Schools are designed to fail.

Former Manafort associate pleads guilty to acting as an unregistered foreign agent

Patten’s case was initially under investigation by the Special Counsel’s Office before being referred over to the Justice Department.

Life-Saving Allergy Treatment Is Becoming Too Expensive For Families To Afford

Over the past nine years, since Mylan bought the rights to the EpiPen, the price for the easy-to-use injectors has quintupled — increasing about 450 percent, from around $50 for one injector to $600 for a pack of two.